EM Basic : PE Part 2

EM Basic : PE Part 2

This episode is part 2 of the PE podcast where we will discuss risk stratification and treatment of PE.  It’s important that we accurately quanitfy the amount of clot burden that the patient has to order the right treatment and admit them (or maybe even discharge them) to the right location.  We’ll talk about how…

Read More
Top 20 Monoclonal Antibodies of 2025 

Top 20 Monoclonal Antibodies of 2025 

Shots:  Redefining treatment paradigms, monoclonal antibody therapies utilize advanced mechanisms of action to provide care across multiple therapeutic areas  As of 2024, the global monoclonal antibody therapy market was valued at $252.6B and is projected to reach $497.5B by 2029, growing at a CAGR of 14.5%. Keytruda leads the market with $29.48B in revenue, followed…

Read More
Exclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight 

Exclusive: A Stimulating Dialogue with Edmund Ben Ami, Co-Founder & CEO of NeuraLight 

Shots:  Given the high variability and subjectivity of traditional clinical scales, there is an urgent need for objective biomarkers to assess CNS disease progression more reliably   NeuraLight is at the forefront of precision neurology, developing objective and sensitive biomarkers that bring greater accuracy and consistency to CNS research   In this exclusive conversation, Edmund Ben Ami,…

Read More